Kalra, M., Tong, Y., Jones, D. R., Walsh, T., Danso, M. A., Ma, C. X., . . . Miller, K. D. (2021). Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)Kalra, Maitri, et al. Cisplatin +/− Rucaparib After Preoperative Chemotherapy in Patients with Triple-negative or BRCA Mutated Breast Cancer. Nature Portfolio, 2021.
Cita MLA (8a ed.)Kalra, Maitri, et al. Cisplatin +/− Rucaparib After Preoperative Chemotherapy in Patients with Triple-negative or BRCA Mutated Breast Cancer. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.